A hemolysis assay tests the ability of nanoparticles to lyse red blood cells. This is important in biological applications to assess biocompatibility and safety, ensuring that nanoparticles do not cause harmful effects when introduced into the bloodstream. Researchers delve into these assays to determine the ultimate impact of nanoparticles on human health and their potential use in drug delivery systems.